Skip to main content
Fig. 2 | International Journal of Retina and Vitreous

Fig. 2

From: Safety and tolerability evaluation after repeated intravitreal injections of a humanized anti-VEGF-A monoclonal antibody (PRO-169) versus ranibizumab in New Zealand white rabbits

Fig. 2

Response-stimulus strength for the dark-adapted ERG b-wave for each ERG recording session (1, 2 and 3-months), from experimental (OD) and the control (OS) eyes. The relationships were fitted to hyperbolic function (Eq. 1) to derive the maximal amplitude response (V/VMax) and the semi saturation constant (σ). For PRO-169 and ranibizumab at each recording session, the response-stimulus energy relationship of the control and experimental eyes are similar

Back to article page